Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Neuromodulation Devices Market by Technology, Applications & Biomaterial - Global Opportunity Analysis & Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 03 Oct 16

Research and Markets has announced the addition of the "Neuromodulation Devices Market by Technology, Applications and Biomaterial - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" report to their offering.

The report projects that the world neuromodulation market is expected to reach $11,717 million by 2022, registering a CAGR of 13.1% from 2016 to 2022. Spinal cord stimulation (SCS) segment is expected to remain the highest, in terms of revenue, throughout the forecast period. North America led the global neuromodulation market in 2015, and is expected to maintain its position throughout the study period.

Amongst the internal neuromodulation devices, spinal cord stimulation (SCS) is highest generator in the global market, owing to the growing number of product approvals and positive clinical outcomes. Deep brain stimulation (DBS) is projected to be the fastest growing segment with a CAGR of 13.9% from 2016 to 2022, due to increasing prevalence of neurological disorders such as Parkinsons disease (PD), epilepsy & dystonia, and lack of existing treatment options.

Pain management was the leading application with one-third share of globalneuromodulation market due to high incidence of conditions characterized by chronic pain and notable relief offered by its use. Failed Back Syndrome (FBSS), Urinary & Fecal Incontinence, and Migraine were other dominant applications for neurostimulators and are expected to control over two-fifths share together by 2022. Further, devices made of polymeric biomaterials are expected to grow with the fastest rate as they are biocompatible and biodegradable.

Companies Mentioned:

  • Medtronic plc
  • St. Jude Medical
  • LivaNova PLC
  • Boston Scientific Corporation
  • Aleva Neurotherapeutics SA
  • BioControl Medical
  • Bioness Inc.
  • EnteroMedics Inc
  • Nevro Corporation
  • NeuroPace Inc.

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

Chapter 4 - World Neuromodulation Market, By Technology

Chapter 5 - World Neuromodulation Market, By Application

Chapter 6 - World Neuromodulation Market, By Biomaterial

Chapter 7 - World Neuromodulation Market, By Geography

Chapter 8 - Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/j4pvk5/neuromodulation

View source version on businesswire.com: http://www.businesswire.com/news/home/20161003005637/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.